Stock Events

Thermo Fisher Scientific 

$540.1
1042
+$4.35+0.81% Friday 20:00

統計

當日最高
540.17
當日最低
533.85
52週最高
603.01
52週最低
414.76
成交量
1,232,009
平均成交量
1,809,031
市值
206.16B
市盈率
34.64
股息收益率
0.29%
股息
1.56

即將到來

股息

0.29%股息收益率
10年增長
10.03%
5年增長率
15.47%
3年增長率
14.47%
1年增長率
11.43%

收益

24Jul確認
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
下一個
4.71
5.04
5.36
5.69
預期每股收益
5.121281
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 TMO 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

627.91$平均價格目標
最高估價為 $670。
來自過去 6 個月內的 11 個評級。這不是投資建議。
買入
82%
持有
18%
賣出
0%

關於

Health Technology
Medical Specialties
Professional, Scientific, and Technical Services
Testing Laboratories
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Show more...
首席執行官
Marc Casper
員工
122000
國家
US
ISIN
US8835561023
WKN
000857209

上市公司